These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27475991)

  • 1. Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control.
    Prohászka Z; Nilsson B; Frazer-Abel A; Kirschfink M
    Immunobiology; 2016 Nov; 221(11):1247-58. PubMed ID: 27475991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.
    Defendi F; Thielens NM; Clavarino G; Cesbron JY; Dumestre-Pérard C
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):229-251. PubMed ID: 31834594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding Horizons in Complement Analysis and Quality Control.
    Frazer-Abel A; Kirschfink M; Prohászka Z
    Front Immunol; 2021; 12():697313. PubMed ID: 34434189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Complement System in the Clinical Immunology Laboratory.
    Ling M; Murali M
    Clin Lab Med; 2019 Dec; 39(4):579-590. PubMed ID: 31668271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement analysis in the era of targeted therapeutics.
    Prohászka Z; Kirschfink M; Frazer-Abel A
    Mol Immunol; 2018 Oct; 102():84-88. PubMed ID: 29933889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international serum standard for application in assays to detect human complement activation products.
    Bergseth G; Ludviksen JK; Kirschfink M; Giclas PC; Nilsson B; Mollnes TE
    Mol Immunol; 2013 Dec; 56(3):232-9. PubMed ID: 23787367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S; Tamura N; Fujita T
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
    Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
    Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of functional activity of components and factors of the human complement system].
    Kozlov LV
    Vopr Med Khim; 2002; 48(6):624-31. PubMed ID: 12698564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Laboratory Testing and Clinical Presentations of Complement Deficiencies and Dysregulation.
    Frazer-Abel A; Sepiashvili L; Mbughuni MM; Willrich MA
    Adv Clin Chem; 2016; 77():1-75. PubMed ID: 27717414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach.
    Grumach AS; Kirschfink M
    Mol Immunol; 2014 Oct; 61(2):110-7. PubMed ID: 25037634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).
    Carpenter CB; Ruddy S; Shehadeh IH; Müller-Eberhard HJ; Merrill JP; Austen KF
    J Clin Invest; 1969 Aug; 48(8):1495-505. PubMed ID: 4894302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays.
    Visentin J; Vigata M; Daburon S; Contin-Bordes C; Fremeaux-Bacchi V; Dromer C; Billes MA; Neau-Cransac M; Guidicelli G; Taupin JL
    Transplantation; 2014 Sep; 98(6):625-31. PubMed ID: 25058376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Complement Analysis-An Overview.
    Skattum L
    Transfus Med Rev; 2019 Oct; 33(4):207-216. PubMed ID: 31672339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External quality assurance program for diagnostic complement laboratories: evaluation of the results of the past seven years.
    Kirschfink M; Frazer-Abel A; Balogh E; Goseberg S; Weiss N; Prohászka Z
    Front Immunol; 2024; 15():1368399. PubMed ID: 38596685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in diagnostic testing of nephritic factors.
    Michels MAHM; Volokhina EB; van de Kar NCAJ; van den Heuvel LPWJ
    Front Immunol; 2022; 13():1036136. PubMed ID: 36451820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and its receptors: new insights into human disease.
    Holers VM
    Annu Rev Immunol; 2014; 32():433-59. PubMed ID: 24499275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of complement function by ELISA.
    Roos A; Wieslander J
    Methods Mol Biol; 2014; 1100():11-23. PubMed ID: 24218247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.